Semler Scientific Under Legal Scrutiny
Pomerantz LLP has announced that a class action lawsuit has been initiated against Semler Scientific, Inc. (NASDAQ: SMLR). This legal action is directed towards investors who believe they have suffered losses related to their investments in Semler. If you identify with this situation, it's crucial to reach out to a legal representative for guidance on the next steps.
Details of the Class Action
The class action lawsuit centers around allegations that Semler and some of its executive officers or directors may have engaged in securities fraud or other unlawful business practices. Investors who acquired or purchased Semler securities during the Class Period are urged to consider their options carefully as the deadline for legal action approaches.
Registration for Lead Plaintiff
Individuals interested in being appointed as Lead Plaintiff have until October 28, 2025, to submit their requests to the court. This opportunity is vital for those who have invested during the Class Period of the lawsuit. More information regarding the complaint is accessible through various legal resources.
Financial Woes and Stock Performance
Recently, Semler disclosed potential issues surrounding its QuantaFlo device. In its annual report, the company indicated that the U.S. Department of Justice (DOJ) might file a complaint related to claims connected with its device. This announcement sent shockwaves through the market, resulting in a significant stock price drop.
On March 3, 2025, Semler's stock fell by $4.03 per share, marking a decrease of 9.4%, as it closed the trading day at $38.89. Shareholders reacted swiftly to the company’s disclosure of the ongoing legal challenges and their potential financial ramifications.
Settlement Discussions
Fast forward to April 15, 2025, Semler announced it had reached an agreement in principle with the DOJ concerning a payment of $29.75 million to resolve the claims. However, this news led to a further decline in Semler’s stock price, which dropped by $3.40 or 9.88%, finishing at $31.00 per share on April 16, 2025.
About Pomerantz LLP
Pomerantz LLP, a premier law firm with a long-standing reputation, has a significant track record in handling corporate, securities, and antitrust class litigation. Established by Abraham L. Pomerantz, who was known as the dean of class action law, the firm has dedicated over 85 years to advocating for the rights of individuals affected by securities fraud and corporate wrongdoings. Their efforts have resulted in substantial financial recoveries for class members.
Contact Information
If you believe you qualify for this class action or have any queries regarding your investment in Semler Scientific, you can contact Danielle Peyton at Pomerantz LLP. It’s important to have professional advice during this time to navigate the complexities of securities law and protect your interests.
Frequently Asked Questions
What is the class action lawsuit against Semler Scientific about?
The lawsuit alleges that Semler and its executives may have engaged in securities fraud or unlawful business practices that negatively impacted investors.
How can I participate in the class action lawsuit?
Investors wishing to join the class action need to express their interest to the court by the October deadline.
What caused Semler's stock to drop?
Semler's stock dropped significantly due to disclosures regarding potential legal action from the DOJ and subsequent settlement announcements.
Who should I contact for more information?
For further inquiries, it is advisable to reach out to legal representatives like those at Pomerantz LLP.
What is Pomerantz LLP's role in this situation?
Pomerantz LLP is representing investors in this class action lawsuit against Semler Scientific, guiding them in the legal processes involved.
